Artificial Intelligence (AI) in Healthcare Market By Function (Imaging, Robotics, AI Scribe, Telehealth, CDS, Precision Medicine, Radiation, RCM, Cybersecurity), Tools (ML, NLP, Computer Vision), End User (Hospital, ASC, Payer) - Global Forecast to 2031

icon1
USD 194.79 BN
MARKET SIZE, 2031
icon2
CAGR 39.7%
(2026-2031)
icon3
738
REPORT PAGES
icon4
455
MARKET TABLES

OVERVIEW

artificial-intelligence-healthcare-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global artificial intelligence (AI) in healthcare market is projected to reach USD 194.79 billion by 2031 from USD 36.67 billion in 2026, at a CAGR of 39.7% during the forecast period. Market growth is driven by rising provider demand for automation, nationwide labor shortages, increasing clinical complexity, and strong investment in predictive analytics, imaging AI, and GenAI. Expanding regulatory support, deeper EHR AI integration, and the shift toward value-based care are further accelerating large-scale uptake.

KEY TAKEAWAYS

  • BY REGION
    By region, the North American artificial intelligence (AI) in healthcare market accounted for the largest share of 42.4% in 2025.
  • BY OFFERING
    By offering, the integrated solutions segment is expected to register the highest CAGR during the forecast period.
  • BY FUNCTION
    By function, the AI Scribe segment is projected to grow at the fastest rate from 2026 to 2031.
  • BY APPLICATION
    By application, the clinical applications segment is expected to register the highest CAGR of 41.4% during the forecast period.
  • BY DEPLOYMENT MODEL
    By deployment model, the cloud-based models segment held the largest share of 63.2% in 2025.
  • BY TOOL
    By tool, the machine learning segment is expected to dominate the market during the forecast period.
  • BY END USER
    By end user, the healthcare providers segment accounted for the largest share of the artificial intelligence in healthcare market.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    Microsoft Corporation, NVIDIA Corporation, and GE HealthCare were identified as the star players in the artificial intelligence (AI) in healthcare market, given their strong market share and product footprint.
  • COMPETITIVE LANDSCAPE - STARTUPS/SMES
    Qventus, Qure.AI, and Segmed have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The artificial intelligence (AI) in healthcare market is experiencing significant growth, driven by the increasing adoption of artificial intelligence technologies across diagnostics, medical imaging, drug discovery, clinical decision support, remote patient monitoring, and healthcare workflow automation. Healthcare organizations are leveraging AI to improve diagnostic accuracy, reduce administrative burden, optimize resource utilization, and enhance patient outcomes.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The artificial intelligence (AI) in healthcare market is shifting as providers, payers, and diagnostics networks adopt AI to improve efficiency, precision, and patient experience. Rising client needs for automation, advanced analytics, and clinical augmentation are driving clear results, including faster decision-making, reduced operational burden, and improved financial performance. The industry is also moving from rule-based tools to cloud-native, predictive, and generative AI platforms. This shift is reshaping the revenue mix and positioning AI as a core enabler of next-generation care delivery.

artificial-intelligence-healthcare-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rapid proliferation of AI in healthcare sector
  • Growing need for improved healthcare services
RESTRAINTS
Impact
Level
  • Shortage of skilled AI professionals handling AI-powered solutions
  • Lack of standardized frameworks for AI and ML technologies
OPPORTUNITIES
Impact
Level
  • Strategic partnerships and collaborations among healthcare companies and AI technology providers
  • Increase in focus on developing human-aware AI systems
CHALLENGES
Impact
Level
  • Concerns regarding data privacy
  • Lack of interoperability

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rapid proliferation of AI in healthcare sector

The development and implementation of artificial intelligence in the healthcare industry are among the main drivers of market growth, fueled by growing government interest in accelerating AI adoption. AI technologies are being implemented in healthcare for various uses, including imaging services, drug development, clinical documentation, disease monitoring, personalized treatment programs, and telemedicine. For example, in April 2026, the UK's Medicines and Healthcare Products Regulatory Agency added USD 4.1 million to the budget of the existing AI Airlock regulatory sandbox project, aimed at supporting the implementation of innovative AI medical devices. All these developments are expected to accelerate the implementation of AI in clinics, thereby supporting further growth in the market.

Restraint: Shortage of skilled AI professionals handling AI-powered solutions

The shortage of experienced AI experts is a restraint to the AI in healthcare market. The development, implementation, and further operation of AI technology demands knowledge and skills in artificial intelligence, data science, machine learning, health information technology, and the regulatory aspects of using AI in healthcare. A lack of highly skilled personnel with adequate experience implementing AI within health information processes can complicate deployment and increase the costs of deploying AI solutions. For example, CDC's 2026 AI Strategy identifies workforce development to ensure the readiness of personnel to adopt AI in disease detection and prevention as one of the organization's key priorities.

Opportunity: Strategic partnerships and collaborations among healthcare companies and AI technology providers

Strategic alliances between healthcare institutions and AI companies represent an opportunity in the AI in healthcare market. Collaborations will lead to the development of new products, faster deployment of technology, and the application of artificial intelligence to diagnostics, treatment, drug development, patient monitoring, and various healthcare operations. Collaboration among players helps harness the benefits of combining clinical knowledge, healthcare data, and artificial intelligence to achieve positive results. For instance, in June 2026, NVIDIA, Foxconn, and major Taiwanese medical institutions partnered on the "Healthy Taiwan" initiative, which aims to introduce agentic AI technologies in hospitals to boost clinical decision-making, coordination, documentation, and operations. The initiative is funded by a USD 1.5 billion investment to advance AI-native infrastructure.

Challenge: Concerns regarding data privacy

Data privacy and security are among the issues that have posed challenges in the AI in healthcare industry, as it involves a large volume of confidential patient data, including electronic medical records, medical imaging, genomics, and monitoring data. With cloud-based computing becoming more common today and healthcare systems more connected than ever, there is a risk of data breaches, cyberattacks, unauthorized access, and even noncompliance. This sector has to adhere to strict data security laws such as HIPAA in the US and the GDPR in Europe, among other regional laws, which makes compliance costly and difficult. For instance, in January 2025, the European Commission initiated an action plan to enhance cybersecurity in all healthcare facilities.

ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Cloud-based AI platforms enabling clinical analytics, NLP-driven documentation, predictive risk modeling, and interoperable EHR-integrated AI workflows. Improved decision-making, scalable AI deployment, enhanced interoperability, and streamlined clinical workflows.
GPU-accelerated AI for imaging, digital twins, drug discovery, and real-time inference through NVIDIA Clara and MONAI ecosystems. Faster diagnostics, accelerated model training, improved precision medicine, and reduced latency.
AI-enabled imaging interpretation, ICU and patient monitoring intelligence, and workflow orchestration across radiology and cardiology environments. Higher diagnostic accuracy, faster reporting cycles, better care coordination, and reduced clinician burden.
AI-driven imaging acquisition, patient monitoring analytics, and predictive maintenance through the Edison AI platform. Quicker image processing, lower workload, improved equipment uptime, and enhanced operational reliability.
AI-based diagnostic imaging, clinical decision support, and pathway optimization via AI-Rad Companion and digital twin technologies. Standardized diagnostic quality, optimized care pathways, more personalized treatment planning, and greater clinical consistency.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The artificial intelligence in healthcare market operates within an interconnected ecosystem that includes technology leaders, health systems, payers, pharmacies, ASCs, home health networks, and research institutions. Enterprise cloud adoption, coupled with strong federal incentives for digital modernization, is accelerating AI integration across clinical, operational, and financial workflows. Providers aim for efficiency, payers focus on cost control, and vendors expand AI-driven platforms. This ecosystem is becoming a mature, innovation-driven market that supports nationwide change in care delivery and healthcare economics.

artificial-intelligence-healthcare-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

artificial-intelligence-healthcare-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Artificial Intelligence (AI) in Healthcare Market, By Offering

Based on offerings, the market is segmented into integrated solutions, niche/point solutions, AI technologies, and services. In 2025, integrated solutions held the largest share due to the growing need for interoperability and seamless data sharing in the healthcare sector to improve administrative and healthcare provision management processes. The preference by healthcare organizations for integrated software that integrates electronic health records (EHR), revenue cycle management, imaging, patient engagement, and analytics platforms to create an ecosystem has increased significantly. An integrated system also simplifies IT operations and ensures that healthcare organizations adopt a value-based approach. For example, in May 2026, Fujitsu and IBM Japan partnered to create a sovereign cloud that facilitates the integration and application of artificial intelligence in the management of healthcare data across multiple healthcare facilities.

Artificial Intelligence (AI) in Healthcare Market, By Function

Based on function, the market is segmented into diagnosis & early detection, treatment planning & personalization, patient engagement & remote monitoring, post-treatment surveillance & survivorship care, pharmacy management, data management & analytics, AI Scribe, CDSS, and administrative functions. In 2025, diagnosis & early detection held the largest share due to the growing use of artificial intelligence-based technologies in medical imaging, disease diagnosis, risk assessment, and clinical decision-making. The use of AI-based algorithms helps healthcare professionals detect diseases at an early stage, enhance diagnostic accuracy, reduce the time required to interpret images, and make prompt decisions about intervention. The rise in the prevalence of chronic diseases, the growing need for personalized medicine, and the use of AI in medical specialties such as radiology, pathology, cardiology, and oncology are also expected to fuel segment growth. For instance, in April 2026, the European Commission launched programs to fund pilot projects that use AI in medical imaging.

Artificial Intelligence (AI) in Healthcare Market, By Application

Based on applications, the market is segmented into clinical applications and non-clinical applications. In 2025, clinical applications accounted for the largest share due to the rising use of artificial intelligence (AI)-based technologies in medical diagnostics, healthcare imaging, clinical decision-making, medical prognosis, treatment planning, and patient monitoring. Healthcare organizations are using AI technology to provide accurate diagnoses, make evidence-based medical decisions, and improve treatment outcomes while reducing the burden on clinicians. Other factors such as the rising incidence of chronic diseases and the need for personalized medicines are also driving the market’s expansion.

Artificial Intelligence (AI) in Healthcare Market, By Deployment Model

Based on deployment models, the market is segmented into on-premise, cloud-based, and hybrid models. Cloud-based deployments held the largest share, driven by their scalability, affordability, flexibility, and capabilities that allow for storing and processing vast amounts of healthcare information. Cloud computing enables healthcare companies to quickly implement AI applications, provide immediate access to data, promote interoperability, and collaborate more effectively across healthcare networks. The growing use of EHRs, telehealth platforms, remote patient monitoring tools, and advanced AI-powered analytics software has driven demand for cloud-based healthcare infrastructure.

Artificial Intelligence (AI) in Healthcare Market, By Tool

Based on tools, the market is segmented into machine learning, natural language processing, context-aware computing, generative AI, computer vision, and image analysis. In 2025, machine learning accounted for a significant share, driven by its broad applications in medical imaging, disease diagnosis, clinical decision-making, predictive analytics, drug discovery, and personalized medicine. By applying machine learning approaches, healthcare companies can analyze large, complex data, identify patterns, predict disease risk, and make data-driven decisions that improve their effectiveness and patients' health. Machine learning technologies' ability to continually learn from new information and develop prediction algorithms enables their wide application across all kinds of healthcare projects. For example, in February 2026, the US Department of Health and Human Services' ARPA-H announced the launch of the Intelligent Generator of Research (IGoR) program, which uses AI techniques to accelerate research and disease modeling.

Artificial Intelligence (AI) in Healthcare Market, By End User

Based on end users, the market is segmented into healthcare providers, healthcare payers, patients, and other end users. In 2025, healthcare providers held the largest share as more AI-driven innovations are deployed for diagnostics, medical imaging, clinical decision support, patient monitoring, workflow management, and clinical documentation purposes. Healthcare institutions are increasingly adopting AI technologies to improve their operations and provide more accurate diagnoses. The rising volume of health-related information, the growing prevalence of chronic conditions, and the emphasis on value-based care practices are all contributing to the increasing adoption of AI in the healthcare sector. For example, in February 2026, M Health Fairview opted for Nabla’s Ambient AI Assistant and Dictation to deploy them systemwide across its network.

REGION

Asia Pacific is fastest-growing region in artificial intelligence (AI) in healthcare market

The Asia Pacific region is the fastest-growing in the AI in healthcare market due to healthcare digitization, increased funding for AI, growth in healthcare infrastructure, and the adoption of AI-based technologies in diagnostics, clinical decision-making, and workflow management in healthcare operations. Also, the region has been supported by favorable government policies and an increased need for effective healthcare. For instance, in March 2026, the Indian Government introduced the Strategy for AI in Healthcare for India (SAHI) and the Benchmarking Open Data Platform for Health AI (BODH), aiming at fostering the safe and ethical implementation of AI at scale in healthcare while validating and scaling the use of AI-driven healthcare innovations.

artificial-intelligence-healthcare-market Region

ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX

Koninklijke Philips N.V. is positioned as a Star in the artificial intelligence in healthcare market based on the scale of its installed base in imaging, monitoring, and clinical informatics. This reach allows broad integration of AI across diagnostic and acute care workflows. Its strong alignment with hospital modernization priorities and its ability to embed AI within enterprise platforms support sustained market leadership. Oracle is emerging as a leader due to its investments in health-focused foundation models, cloud infrastructure, and data management capabilities. Its growing collaborations with research institutions and life sciences organizations are strengthening its role in advancing next-generation clinical and analytical AI applications.

artificial-intelligence-healthcare-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 25.88 Billion
Market Forecast in 2026 (Value) USD 36.67 Billion
Market Forecast in 2031 (Value) USD 194.79 Billion
CAGR 39.7%
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered USD Million/Billion
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Offering:
    • Integrated Solutions
    • Niche/Point Solutions
    • AI Technologies
    • Services
  • By Function:
    • Diagnosis & Early Detection
    • Treatment Planning & Personalization
    • Patient Engagement & Remote Monitoring
    • Post-treatment Surveillance & Survivorship Care
    • Pharmacy Management
    • Data Management & Analytics
    • AI Scribe
    • Clinical Decision Support System
    • Administrative
  • By Application:
    • Clinical Applications
    • Non-Clinical Applications
  • By Deployment Model:
    • On-premise Models
    • Cloud-based Models
    • Hybrid Models
  • By Tool:
    • Machine Learning
    • Natural Language Processing (NLP)
    • Context-aware Computing
    • Generative AI
    • Computer Vision
    • Image Analysis
  • By End User:
    • Healthcare Providers
    • Healthcare Payers
    • Patients
    • Other End Users
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET REPORT CONTENT GUIDE

artificial-intelligence-healthcare-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Map the AI healthcare ecosystem Comprehensive ecosystem mapping across vendors, providers, payers, pharmacies, ASCs, home health, research bodies, and regulators Clear visibility into market structure and interaction points to guide partnerships and investment decisions
Understand AI integration with healthcare infrastructure Deep analysis of AI–EHR interoperability, cloud deployment models, data-sharing frameworks, and compliance requirements (HIPAA, ONC, CMS) Reduces integration risk and informs technology roadmap aligned to regulatory and data ecosystem
Identify high-ROI AI use cases for providers and payers Prioritize use-case assessment across clinical, operational, financial, and patient-experience domains Enables targeted product development and stronger go-to-market focus in high-value segments
Benchmark competitors in the AI landscape Capability benchmarking across major AI vendors (Microsoft, NVIDIA, Oracle Health, GE, Philips, AWS, Google) Strengthens competitive positioning and identifies whitespace opportunities for differentiation
Assess policy, reimbursement, and regulatory impacts on AI adoption Analysis of FDA AI/ML SaMD guidelines, CMS reimbursement pathways, Medicare Advantage analytics trends Improves product compliance strategy and enhances commercialization feasibility

RECENT DEVELOPMENTS

  • April 2026 : GE HealthCare and DeepHealth partnered to deliver AI-powered breast cancer screening solutions to healthcare providers worldwide via mammography and imaging platforms.
  • March 2026 : Philips and Amazon Web Services expanded cloud-enabled digital pathology and AI diagnostics capabilities through HealthSuite, enabling scalable AI-powered pathology workflows.
  • February 2026 : Siemens Healthineers and Mayo Clinic expanded their collaboration to advance AI-enabled MRI protocols and imaging technologies for neurodegenerative disease and oncology applications.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
 
 
 
 
 
 
5.1
PORTER'S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
INDICATIVE PRICE FOR AI IN HEALTHCARE SOLUTIONS, BY OFFERING (2025)
 
 
 
 
 
5.5.2
INDICATIVE PRICE FOR AI IN HEALTHCARE SOLUTIONS, BY REGION (2025)
 
 
 
 
5.6
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
5.8
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
5.9
CASE STUDY ANALYSIS
 
 
 
 
 
5.10
IMPACT OF 2025 US TARIFFS ON AI IN HEALTHCARE MARKET
 
 
 
 
 
 
 
5.10.1
INTRODUCTION
 
 
 
 
 
5.10.2
KEY TARIFF RATES
 
 
 
 
 
5.10.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.10.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
5.10.4.1
US
 
 
 
 
 
5.10.4.2
EUROPE
 
 
 
 
 
5.10.4.3
ASIA PACIFIC
 
 
 
 
5.10.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
7
REGULATORY LANDSCAPE
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
INTRODUCTION
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS & THEIR EVALUATION CRITERIA
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
9
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY OFFERING (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
INTEGRATED SOLUTIONS
 
 
 
 
 
9.3
NICHE/POINT SOLUTIONS
 
 
 
 
 
9.4
AI TECHNOLOGIES
 
 
 
 
 
9.5
SERVICES
 
 
 
 
10
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY FUNCTION (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
DIAGNOSIS & EARLY DETECTION
 
 
 
 
 
 
10.2.1
PRE-SCREENING
 
 
 
 
 
10.2.2
IVD
 
 
 
 
 
 
10.2.2.1
BY TECHNOLOGY
 
 
 
 
 
 
10.2.2.1.1
IMMUNOASSAYS
 
 
 
 
 
10.2.2.1.2
CLINICAL CHEMISTRY
 
 
 
 
 
10.2.2.1.3
MOLECULAR DIAGNOSTICS
 
 
 
 
10.2.2.2
BY APPLICATION
 
 
 
 
 
 
10.2.2.2.1
IMAGE ANALYSIS & INTERPRETATION
 
 
 
 
 
10.2.2.2.2
BIOMARKER DISCOVERY & ANALYSIS
 
 
 
 
 
10.2.2.2.3
OTHER IVD APPLICATIONS
 
 
 
10.2.3
DIAGNOSTIC IMAGING
 
 
 
 
 
 
10.2.3.1
BY APPLICATION
 
 
 
 
 
 
10.2.3.1.1
DISEASE INTERPRETATION & REPORT ANALYSIS
 
 
 
 
 
10.2.3.1.2
IMAGE CAPTIONING & ANNOTATION
 
 
 
 
 
10.2.3.1.3
IMAGE RECONSTRUCTION
 
 
 
 
 
10.2.3.1.4
OTHER DIAGNOSTIC IMAGING APPLICATIONS
 
 
 
 
10.2.3.2
BY MODALITY
 
 
 
 
 
 
10.2.3.2.1
MAGNETIC RESONANCE IMAGING (MRI)
 
 
 
 
 
10.2.3.2.2
COMPUTED TOMOGRAPHY (CT)
 
 
 
 
 
10.2.3.2.3
X-RAY IMAGING
 
 
 
 
 
10.2.3.2.4
ULTRASOUND
 
 
 
 
 
10.2.3.2.5
NUCLEAR IMAGING (PET & SPECT)
 
 
 
 
 
10.2.3.2.6
OTHER MODALITIES (OPTICAL IMAGING, ETC)
 
 
 
10.2.4
RISK ASSESSMENT & PATIENT STRATIFICATION
 
 
 
 
 
10.2.5
DRUG ALLERGY ALERTING
 
 
 
 
 
10.2.6
OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS
 
 
 
 
10.3
TREATMENT PLANNING & PERSONALIZATION
 
 
 
 
 
 
10.3.1
PERSONALIZED TREATMENT PLANNING
 
 
 
 
 
 
10.3.1.1
PRECISION MEDICINE & GENOMIC ANALYSIS
 
 
 
 
 
10.3.1.2
PREDICTIVE MODELS FOR TREATMENT RESPONSE
 
 
 
 
 
10.3.1.3
TREATMENT RECOMMENDATION SYSTEMS
 
 
 
 
10.3.2
PHARMACOLOGICAL THERAPY
 
 
 
 
 
 
10.3.2.1
DRUG RESPONSE PREDICTION
 
 
 
 
 
10.3.2.2
DOSING & ADMINISTRATION
 
 
 
 
 
10.3.2.3
OTHER PHARMACOLOGICAL THERAPY FUNCTIONS
 
 
 
 
10.3.3
SURGICAL THERAPY
 
 
 
 
 
 
10.3.3.1
PREOPERATIVE IMAGING AND 3D MODELING
 
 
 
 
 
10.3.3.2
INTRAOPERATIVE GUIDANCE AND ROBOTICS
 
 
 
 
 
10.3.3.3
POSTOPERATIVE ANALYSIS & RECOVERY
 
 
 
 
10.3.4
RADIATION THERAPY
 
 
 
 
 
 
10.3.4.1
MOTION SYNCHRONIZATION & AUTO CONTOURING
 
 
 
 
 
10.3.4.2
REAL-TIME ADAPTIVE TREATMENT DELIVERY
 
 
 
 
 
10.3.4.3
RESPONSE ASSESSMENT & QUALITY ASSURANCE
 
 
 
 
 
10.3.4.4
OTHER RADIATION THERAPY FUNCTIONS
 
 
 
 
10.3.5
BEHAVIORAL & PSYCHOTHERAPY THERAPY
 
 
 
 
 
 
10.3.5.1
VIRTUAL COUNSELLING & CHATBOTS
 
 
 
 
 
10.3.5.2
PROGRESS MONITORING & FEEDBACK
 
 
 
 
 
10.3.5.3
FOLLOW-UP & LONG-TERM SUPPORT
 
 
 
 
10.3.6
IMMUNOTHERAPY
 
 
 
 
 
 
10.3.6.1
REAL-TIME PATIENT DATA MONITORING (IMAGING SCANS, BLOOD BIOMARKERS, VITALS)
 
 
 
 
 
10.3.6.2
RESPONSE & SIDE EFFECT PREDICTION
 
 
 
 
 
10.3.6.3
RELAPSE PREDICTION AND LONG-TERM MANAGEMENT
 
 
 
 
10.3.7
OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS
 
 
 
 
10.4
PATIENT ENGAGEMENT & REMOTE MONITORING
 
 
 
 
 
 
10.4.1
SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE
 
 
 
 
 
10.4.2
TELEHEALTH & REMOTE PATIENT MONITORING
 
 
 
 
 
10.4.3
HEALTHCARE ASSISTANCE ROBOTS
 
 
 
 
 
10.4.4
MEDICATION REMINDERS
 
 
 
 
 
10.4.5
PATIENT EDUCATION & EMPOWERMENT
 
 
 
 
 
10.4.6
OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS
 
 
 
 
10.5
POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE
 
 
 
 
 
 
10.5.1
RECURRENCE MONITORING
 
 
 
 
 
10.5.2
LONG-TERM OUTCOME PREDICTION
 
 
 
 
 
10.5.3
MENTAL HEALTH & SUPPORT SYSTEMS
 
 
 
 
10.6
PHARMACY MANAGEMENT
 
 
 
 
 
 
10.6.1
EPRESCRIBING
 
 
 
 
 
10.6.2
MEDICATION MANAGEMENT
 
 
 
 
 
10.6.3
PHARMACY AUDIT & ANALYSIS
 
 
 
 
 
10.6.4
OTHER PHARMACY MANAGEMENT FUNCTIONS
 
 
 
 
10.7
DATA MANAGEMENT & ANALYTICS
 
 
 
 
 
10.8
AI SCRIBE
 
 
 
 
 
10.9
CLINICAL DECISION SUPPORT (CDSS)
 
 
 
 
 
10.10
ADMINISTRATIVE
 
 
 
 
 
 
10.10.1
PATIENT REGISTRATION & SCHEDULING
 
 
 
 
 
10.10.2
PATIENT ELIGIBILITY & AUTHORIZATION
 
 
 
 
 
10.10.3
REVENUE CYCLE MANAGEMENT
 
 
 
 
 
10.10.4
WORKFORCE MANAGEMENT
 
 
 
 
 
10.10.5
SUPPLY CHAIN & INVENTORY MANAGEMENT
 
 
 
 
 
10.10.6
COMPLIANCE & DOCUMENTATION
 
 
 
 
 
10.10.7
HEALTHCARE WORKFLOW MANAGEMENT
 
 
 
 
 
10.10.8
ASSET MANAGEMENT
 
 
 
 
 
10.10.9
CUSTOMER RELATIONSHIP MANAGEMENT
 
 
 
 
 
10.10.10
FRAUD DETECTION & RISK MANAGEMENT
 
 
 
 
 
10.10.11
CYBERSECURITY
 
 
 
 
 
10.10.12
OTHER ADMINISTRATIVE FUNCTIONS
 
 
 
11
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
CLINICAL APPLICATIONS
 
 
 
 
 
11.3
NON-CLINICAL APPLICATIONS
 
 
 
 
12
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
ON-PREMISE MODELS
 
 
 
 
 
12.3
CLOUD-BASED MODELS
 
 
 
 
 
12.4
HYBRID MODELS
 
 
 
 
13
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TOOL (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.2
MACHINE LEARNING
 
 
 
 
 
 
13.2.1
DEEP LEARNING
 
 
 
 
 
 
13.2.1.1
CONVOLUTIONAL NEURAL NETWORKS (CNN)
 
 
 
 
 
13.2.1.2
RECURRENT NEURAL NETWORKS (RNN)
 
 
 
 
 
13.2.1.3
GENERATIVE ADVERSARIAL NETWORKS (GAN)
 
 
 
 
 
13.2.1.4
GRAPH NEURAL NETWORKS (GNN)
 
 
 
 
 
13.2.1.5
OTHER DEEP LEARNING TOOLS
 
 
 
 
13.2.2
SUPERVISED LEARNING
 
 
 
 
 
13.2.3
REINFORCEMENT LEARNING
 
 
 
 
 
13.2.4
UNSUPERVISED LEARNING
 
 
 
 
 
13.2.5
OTHER MACHINE LEARNING TOOLS
 
 
 
 
13.3
NATURAL LANGUAGE PROCESSING
 
 
 
 
 
 
13.3.1
SENTIMENT ANALYSIS
 
 
 
 
 
13.3.2
PATTERN & IMAGE RECOGNITION
 
 
 
 
 
13.3.3
AUTO CODING
 
 
 
 
 
13.3.4
CLASSIFICATION & CATEGORIZATION
 
 
 
 
 
13.3.5
TEXT ANALYTICS
 
 
 
 
 
13.3.6
SPEECH RECOGNITION
 
 
 
 
13.4
CONTEXT-AWARE COMPUTING
 
 
 
 
 
 
13.4.1
DEVICE CONTEXT
 
 
 
 
 
13.4.2
USER CONTEXT
 
 
 
 
 
13.4.3
PHYSICAL CONTEXT
 
 
 
 
13.5
GENERATIVE AI
 
 
 
 
 
13.6
COMPUTER VISION
 
 
 
 
 
13.7
IMAGE ANALYSIS
 
 
 
 
14
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
 
14.2
HEALTHCARE PROVIDERS
 
 
 
 
 
 
14.2.1
HOSPITALS & CLINICS
 
 
 
 
 
14.2.2
AMBULATORY CARE CENTERS & OUTPATIENT SETTING
 
 
 
 
 
14.2.3
HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES
 
 
 
 
 
14.2.4
DIAGNOSTIC & IMAGING CENTERS
 
 
 
 
 
14.2.5
PHARMACIES
 
 
 
 
 
14.2.6
OTHER HEALTHCARE PROVIDERS
 
 
 
 
14.3
HEALTHCARE PAYERS
 
 
 
 
 
 
14.3.1
PUBLIC PAYERS
 
 
 
 
 
14.3.2
PRIVATE PAYERS
 
 
 
 
14.4
PATIENTS
 
 
 
 
 
14.5
OTHER END USERS
 
 
 
 
15
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031)
Market Size, Volume & Forecast – USD Million
 
 
 
 
 
 
15.1
INTRODUCTION
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
15.2.1
US
 
 
 
 
 
15.2.2
CANADA
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
15.3.1
GERMANY
 
 
 
 
 
15.3.2
FRANCE
 
 
 
 
 
15.3.3
UK
 
 
 
 
 
15.3.4
ITALY
 
 
 
 
 
15.3.5
SPAIN
 
 
 
 
 
15.3.6
REST OF EUROPE
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
15.4.1
CHINA
 
 
 
 
 
15.4.2
JAPAN
 
 
 
 
 
15.4.3
INDIA
 
 
 
 
 
15.4.4
AUSTRALIA
 
 
 
 
 
15.4.5
SOUTH KOREA
 
 
 
 
 
15.4.6
REST OF ASIA PACIFIC
 
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
 
15.5.1
BRAZIL
 
 
 
 
 
15.5.2
MEXICO
 
 
 
 
 
15.5.3
REST OF LATIN AMERICA
 
 
 
 
15.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
15.6.1
GCC COUNTRIES
 
 
 
 
 
 
15.6.1.1
SAUDI ARABIA
 
 
 
 
 
15.6.1.2
UAE
 
 
 
 
 
15.6.1.3
REST OF GCC COUNTRIES
 
 
 
 
15.6.2
SOUTH AFRICA
 
 
 
 
 
15.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
16
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
16.1
OVERVIEW
 
 
 
 
 
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN (JANUARY 2023–MAY 2026)
 
 
 
 
 
16.3
REVENUE ANALYSIS (2021–2025)
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS (2025)
 
 
 
 
 
 
16.5
BRAND COMPARISON
 
 
 
 
 
 
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
 
16.6.1
STARS
 
 
 
 
 
16.6.2
EMERGING LEADERS
 
 
 
 
 
16.6.3
PERVASIVE PLAYERS
 
 
 
 
 
16.6.4
PARTICIPANTS
 
 
 
 
 
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
16.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
16.6.5.2
REGION FOOTPRINT
 
 
 
 
 
16.6.5.3
DEPLOYMENT MODEL FOOTPRINT
 
 
 
 
 
16.6.5.4
TOOLS FOOTPRINT
 
 
 
 
 
16.6.5.5
END-USER FOOTPRINT
 
 
 
16.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
 
16.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
16.7.2
DYNAMIC COMPANIES
 
 
 
 
 
16.7.3
RESPONSIVE COMPANIES
 
 
 
 
 
16.7.4
STARTING BLOCKS
 
 
 
 
 
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
16.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
16.8
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
16.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
16.9.1
PRODUCT LAUNCHES & UPGRADES
 
 
 
 
 
16.9.2
DEALS
 
 
 
 
 
16.9.3
EXPANSIONS
 
 
 
 
 
16.9.4
OTHER DEVELOPMENTS
 
 
 
17
COMPANY PROFILES
 
 
 
 
 
 
17.1
KEY PLAYERS
 
 
 
 
 
 
17.1.1
KONINKLIJKE PHILIPS N.V.
 
 
 
 
 
17.1.2
MICROSOFT CORPORATION
 
 
 
 
 
17.1.3
SIEMENS HEALTHINEERS AG
 
 
 
 
 
17.1.4
NVIDIA CORPORATION
 
 
 
 
 
17.1.5
EPIC SYSTEMS CORPORATION
 
 
 
 
 
17.1.6
GE HEALTHCARE
 
 
 
 
 
17.1.7
MEDTRONIC
 
 
 
 
 
17.1.8
ORACLE
 
 
 
 
 
17.1.9
VERADIGM, LLC
 
 
 
 
 
17.1.10
MERATIVE
 
 
 
 
 
17.1.11
GOOGLE
 
 
 
 
 
17.1.12
RIVERIAN TECHNOLOGIES
 
 
 
 
 
17.1.13
JOHNSON & JOHNSON
 
 
 
 
 
17.1.14
AMAZON WEB SERVICES
 
 
 
 
 
17.1.15
SOPHIA GENETICS
 
 
 
 
 
17.1.16
CONCERTAI
 
 
 
 
 
17.1.17
IBM
 
 
 
 
 
17.1.18
COGNIZANT
 
 
 
 
 
17.1.19
TEMPUS
 
 
 
 
 
17.1.20
SOLVENTUM CORPORATION
 
 
 
 
 
17.1.21
VIZ.AI
 
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
 
1.1.1
QVENTUS
 
 
 
 
 
1.1.2
QURE.AI
 
 
 
 
 
1.1.3
SUKI AI, INC.
 
 
 
 
 
1.1.4
ENLITIC, INC.
 
 
 
 
 
1.1.5
SEGMED
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
 
18.1
RESEARCH DATA
 
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.1.2
LIST OF KEY SECONDARY SOURCES
 
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
18.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
18.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
18.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
18.2.2
TOP-DOWN APPROACH
 
 
 
 
 
18.2.3
BASE NUMBER CALCULATION
 
 
 
 
18.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
18.3.1
SUPPLY SIDE
 
 
 
 
 
18.3.2
DEMAND SIDE
 
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
 
18.5
FACTOR ANALYSIS
 
 
 
 
 
18.6
RESEARCH ASSUMPTIONS & LIMITATIONS
 
 
 
 
 
18.7
RESEARCH LIMITATIONS & RISK ASSESSMENT
 
 
 
 
 
18.8
RISK ASSESSMENT
 
 
 
 
19
APPENDIX
 
 
 
 
 
 
19.1
DISCUSSION GUIDE
 
 
 
 
 
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
 
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
19.4
RELATED REPORTS
 
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 
 

Methodology

The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.

Secondary Research

This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.

Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.

Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.

After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.

In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.

Artificial Intelligence in Healthcare Market 
 Size, and Share

Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).

Artificial Intelligence in Healthcare Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.

Market Definition

The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.

Key Stakeholders

  • Artificial intelligence (AI) in healthcare software vendors
  • Artificial intelligence (AI) in healthcare service providers
  • Independent software vendors (ISVs)
  • Platform providers
  • Technology providers
  • System integrators
  • Cloud service providers
  • Healthcare IT service providers
  • Hospitals and surgical centers
  • Diagnostic imaging centers
  • Academic institutes and research laboratories
  • Forums, alliances, and associations
  • Government organizations
  • Institutional investors and investment banks
  • Investors/Shareholders
  • Venture capitalists
  • Research and consulting firms

Report Objectives

  • To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
  • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
  • To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
  • To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
  • Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others

 

Key Questions Addressed by the Report

What near-term strategies can companies adopt to scale revenue in the AI in healthcare market?

Companies should focus on developing integrated AI platforms that combine analytics, EHR, imaging, and workflow automation into a single ecosystem. Additionally, adopting AI-as-a-Service (AIaaS) and subscription-based models can unlock recurring revenue streams, especially as hospitals increasingly shift toward cloud-based deployments and scalable solutions.

How is AI transforming early diagnosis and clinical decision-making?

AI is significantly improving diagnostic accuracy and early disease detection, particularly in radiology, pathology, and genomics. Machine learning models analyze large datasets to identify patterns that enable early identification of diseases like cancer and cardiovascular disorders, ultimately improving patient outcomes and reducing treatment costs.

What role does cloud-based deployment play in accelerating AI adoption in healthcare?

Cloud-based AI solutions are driving adoption due to their scalability, cost efficiency, and real-time data accessibility. Healthcare providers can deploy AI tools across multiple facilities, enabling centralized data analytics, remote monitoring, and faster decision-making without heavy infrastructure investments.

How is AI enabling personalized medicine and precision healthcare?

AI enables personalized medicine by analyzing patient-specific data such as genomics, clinical history, and lifestyle factors. This allows healthcare providers to deliver tailored treatment plans and predictive care strategies, enhancing treatment efficacy and improving long-term patient outcomes.

What are the key growth drivers of the AI in healthcare market?

The market is driven by the growing volume of healthcare data, rising demand for improved diagnostic accuracy, increasing need for cost optimization, and advancements in machine learning and predictive analytics. Additionally, the shift toward value-based care and digital transformation in healthcare systems is accelerating adoption.

What are the major challenges limiting AI adoption in healthcare?

Key challenges include lack of standardized regulatory frameworks, shortage of skilled AI professionals, and resistance from healthcare practitioners toward adopting AI-driven systems. Data privacy concerns and integration complexities with legacy systems also pose barriers to large-scale deployment.

How are emerging technologies shaping the future of AI in healthcare?

Technologies such as natural language processing (NLP), computer vision, and generative AI are reshaping healthcare workflows by enabling automated clinical documentation, advanced imaging analysis, and predictive insights. These innovations are expected to enhance operational efficiency and clinical outcomes significantly.

What key trends should stakeholders monitor to stay competitive in this market?

Key trends include the rise of AI-powered clinical applications, voice-enabled assistants, predictive analytics, and AI-driven workflow automation. Additionally, increasing collaboration between healthcare providers and tech companies is accelerating innovation and expanding AI use cases across the care continuum.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Artificial Intelligence (AI) in Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Artificial Intelligence (AI) in Healthcare Market

Aiden

Apr, 2026

We are currently evaluating how AI integrates with hospital systems using EDI, HL7, and FHIR standards. How mature is interoperability in real-world deployments, and what challenges should we expect?.

Ethan

Apr, 2026

We are exploring AI-led automation in operating rooms and sterile processing. Are there proven use cases delivering measurable efficiency or cost savings?.

Mason

Apr, 2026

As a company in automated medical claims processing, we want to understand how AI improves accuracy and fraud detection. What ROI benchmarks are realistic?.

Logan

Apr, 2026

From an acute hospital perspective, which departments see the fastest ROI from AI adoption?.

Lucas

Apr, 2026

We are assessing vendors in AI healthcare. How do large players compare with niche startups in terms of scalability and innovation?.

Oliver

Apr, 2026

With convergence of medical and computer science, what skillsets are most critical for AI adoption in healthcare?.

Gabriel

Apr, 2026

We are preparing internal presentations. Does the report include quantified AI impact and real-world use cases?.

Levi

Apr, 2026

How is AI impacting healthcare jobs—more automation or creation of new roles?.

Carter

Apr, 2026

How is AI improving care continuity between hospitals and post-acute settings?.

Blake

Apr, 2026

Radiology seems mature for AI. Is there still room for new entrants or is the market consolidating?.

Grant

Apr, 2026

We are exploring AI in ophthalmology. Are these solutions widely adopted clinically or still emerging?.

Parker

Apr, 2026

How is AI expected to shape the future of radiology in terms of diagnostic accuracy and workflow efficiency?.

Dylan

Apr, 2026

How can AI be effectively integrated into healthcare process management to improve hospital operational efficiency?.

Jordan

Apr, 2026

How is AI for imaging improving diagnostic precision and supporting faster clinical decision-making in healthcare systems?.

Trevor

Apr, 2026

Can AI applications used in manufacturing, such as predictive maintenance, be relevant for improving healthcare operational models?.

Logan

Apr, 2026

How is AI integration in MRI helping to reduce scan time while improving image quality and diagnostic outcomes?.

Seth

Apr, 2026

How are AI healthcare solutions enabling better integration of diagnostics, hospital operations, and supply chain management?.

Tyler

Apr, 2026

How is AI contributing to One Health research by linking human, animal, and environmental health data?.

Luke

Apr, 2026

How can AI improve patient monitoring and safety in ambulatory surgery and non-operating room anesthesia settings?.

Ashton

Apr, 2026

How is AI being used in hospital engineering systems to improve infrastructure reliability and equipment performance?.

Gavin

Apr, 2026

How is AI enhancing healthcare informatics and data integration for better clinical decision-making?.

Jace

Apr, 2026

What role does AI governance play in ensuring compliance, transparency, and ethical use of AI in healthcare?.

Brandon

Apr, 2026

How are industry associations influencing the standardization and adoption of AI in healthcare ecosystems?.

Easton

Apr, 2026

How is AI being applied in ophthalmology to enhance retinal imaging and early disease detection capabilities?.

Hudson

Apr, 2026

How is digital transformation accelerating the adoption of AI-driven solutions in healthcare operations and clinical decision-making?.

Rhett

Apr, 2026

How are AI and data science reshaping healthcare workflows, diagnostics, and predictive analytics across hospital ecosystems?.

Tristan

Apr, 2026

Can you provide more insights on Segmed and its role among top AI healthcare companies mentioned in the report?.

Preston

Apr, 2026

How is predictive AI being applied in cardiovascular disease detection and early clinical risk assessment?.

Colton

Apr, 2026

What is the current market size and competitive landscape for AI in healthcare, and how is it expected to evolve?.

Emerson

Apr, 2026

How is AI transforming radiology in terms of imaging accuracy, automation, and clinical efficiency?.

Maddox

Apr, 2026

How is AI helping bridge healthcare accessibility gaps and improving equity in underserved regions?.

Antonio

Apr, 2026

How are clinical applications of AI in healthcare driving improvements in diagnosis, treatment planning, and hospital operations efficiency?.

Dominic

Apr, 2026

How is AI being used in infection control systems to improve early detection, prevention, and hospital-wide safety management?.

Brandon

Apr, 2026

What are the most impactful use cases of AI in healthcare across diagnostics, imaging, operations, and patient management?.

Calvin

Apr, 2026

How is AI currently transforming the healthcare industry in terms of clinical decision-making, workflow automation, and predictive analytics?.

Justin

Apr, 2026

What is the role of medtech semantics in improving interoperability and structured data usage in AI-driven healthcare systems?.

Preston

Apr, 2026

Which AI-powered medical imaging tools are currently most effective in enhancing diagnostic accuracy and radiology workflows?.

Elliot

Apr, 2026

How is AI being applied in healthcare education and the medical industry to improve training, simulation, and clinical learning outcomes?.

Adrian

Apr, 2026

What are the key challenges faced by the AI healthcare market in Europe, especially around regulation, data privacy, and adoption barriers?.

Spencer

Apr, 2026

Can you provide more insights into the global medical AI market size, growth drivers, and future opportunities?.

Jonah

Apr, 2026

How is AI being used to connect quality management systems (eQMS) with IT and OT environments in healthcare organizations?.

Patrick

Apr, 2026

What are the current diagnostic and technological trends shaping the future of healthcare and medical AI applications?.

Caleb

Apr, 2026

How are healthcare and AI technologies converging to reshape diagnostics, treatment planning, and hospital efficiency?.

Mason

Apr, 2026

What is the role of AI in healthcare utilization analysis and cost optimization across hospital systems and payers?.

Cole

Apr, 2026

How is AI transforming healthcare utilization and cost trends across hospitals, payers, and clinical operations?.

Tyler

Apr, 2026

How is AI being applied in healthcare operations to improve efficiency, resource planning, and patient flow management?.

Luke

Apr, 2026

What are the key challenges and implementation barriers for AI adoption in healthcare systems at scale?.

Owen

Apr, 2026

How are emerging medical devices for skin care leveraging AI and digital technologies for improved diagnostics and treatment outcomes?.

Eli

Apr, 2026

How are healthcare professionals with EHR/EMR and clinical experience transitioning into AI-driven healthcare analytics and non-clinical roles?.

Mason

Apr, 2026

What are the most in-demand non-clinical career opportunities in healthcare driven by digital transformation and AI adoption?.

Ryan

Apr, 2026

How are EDI and FHIR standards improving healthcare data interoperability and enabling seamless system integration?.

Adam

Apr, 2026

How is AI improving healthcare data quality, analytics, and decision-making in clinical and operational environments?.

Caleb

Apr, 2026

What is the overall impact of AI on the HealthTech ecosystem in terms of innovation, efficiency, and patient outcomes?.

Logan

Apr, 2026

How is pathology being transformed through AI-enabled diagnostics and digital imaging technologies?.

Ethan

Apr, 2026

How is AI improving healthcare administration processes such as scheduling, billing, and operational efficiency?.

Ryan

Apr, 2026

How is bioproduction being optimized through digital transformation and AI-driven process improvements?.

Cole

Apr, 2026

What are the key funding opportunities and investment trends driving AI innovation in healthcare development?.

James

Apr, 2026

From a hospital procurement standpoint, what are the biggest hidden costs when implementing AI solutions in clinical workflows?.

Emily

Apr, 2026

How scalable are AI healthcare solutions across mid-sized hospitals compared to large health systems?.

Michael

Apr, 2026

What are the main barriers to clinician trust in AI-driven diagnostics, and how can companies address them?.

Olivia

Apr, 2026

From an investor perspective, where do you see the highest ROI segments within AI in healthcare over the next 5 years?.

David

Apr, 2026

How challenging is it to integrate AI solutions with existing hospital IT ecosystems, especially legacy systems?.

winsay

May, 2022

Interested about how AI will change the treatment process and its benefits. .

Payush

Nov, 2017

I was going through the ToC of AI in Healthcare market, I would like to understand, what are the requirements to perform in the fields of AI? .

Payush

Nov, 2017

I was going through the ToC of AI in Healthcare market, I would like to understand, what are the requirements to perform in the fields of AI? .

Riju

Dec, 2018

We have specific interests in global AI in healthcare market and the US AI in healthcare market. Any further details related to market size of AI for early disease detection (for global and USA) would be appreciated. .

Asghar

Feb, 2019

I am looking to purchase this report to see the implications of AI on the workforce in Norway..

Tanuj

May, 2019

I am interested in understanding the market size and related insights on computer-assisted physician documentation (CAPD), clinical documentation improvement (CDI), computer-assisted coding (CAC), ambient voice and voice assistants, NLP, and machine learning for clinical, operational, and financial healthcare scenarios in AI in healthcare..

Narayan

Dec, 2019

I am an automation enthusiast and would like to understand the impact of AI in healthcare. Could you provide me some brochure and sample to get into details..

Kevin

May, 2019

I am conducting a research project on AI in healthcare as a part of my MHA/MBA marketing course. Could you share some relevant information in the form of sample brochure and estimated cost of the report, post discount mentioned on the website?.

Vishal

Feb, 2019

We are redeveloping our chart for Artificial Intelligence in Healthcare Market. Does your report covers regional market insights..

Show More
DMCA.com Protection Status